AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$235,000-15.5% YoY

Gross Profit

$223,00094.9% margin

Operating Income

-$24M-10034.0% margin

Net Income

-$19M-7917.9% margin

EPS (Diluted)

$-0.58

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$34M

Total Liabilities

$14M

Stockholders' Equity

$20M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$235,000	$278,000	-15.5%
Gross Profit	$223,000	$241,000	-7.5%
Operating Income	-$24M	-$17M	-36.4%
Net Income	-$19M	-$17M	-11.8%

AUPH FY 2015 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena